Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva, Murphy Formalize North America Headquarters Move with Ceremony in Israel - New Jersey Business Magazine
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceutical set for major layoffs in Israel, U.S.: report | Reuters
Teva Pharmaceutical Industries | World Economic Forum
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing | Ctech
Former Teva officials said to return $50m over fines paid by drugmaker | The Times of Israel
Teva buys rights for Israeli co Biolojic's asthma treatment - Globes
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva Offers Update On Operations In Israel :: Generics Bulletin
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger - WSJ
These Israeli pharmaceutical stocks are down in the wake of Hamas attack - MarketWatch
InnovationRx: Israel Makes Up 8% Of Teva's Global Production
Teva says Israel-Hamas war not hurting production, eyes growth in 2024 | Reuters
Teva Pharmaceuticals found liable for role in New York opioid epidemic - UPI.com
Israeli pharmaceutical giant Teva investigating bribery accusations in Romania | The Times of Israel
Teva Pharmaceutical to Cut 14,000 Jobs - WSJ
Teva Pharmaceuticals at heart of major price fixing suit in US – www.israelhayom.com
Israel Not Aiming to Punish Teva on Job Cuts, Official Says - Bloomberg
In Israel's largest acquisition, Teva buys Allergan Generics for $40.5b - The Jerusalem Post
Israeli Pharma Giant Teva to Pay Nevada $193 Million Over Role in Opioid Epidemic - Israel News - Haaretz.com
Teva to pay $225 million to settle cholesterol drug price-fixing charges | The Times of Israel
Teva Selling Jerusalem Land Tenure Rights Ahead of Factory Closures | Ctech
Teva Pharmaceuticals Sterile Manufacturing Facility, Ulm - Pharmaceutical Technology
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Opioid Manufacturer Teva Pharmaceuticals Reaches $4B Global Settlement | Law.com
